Lidocaine Prilocaine Zentiva (Lidocaine, Prilocaine)

Both lidocaine and prilocaine block voltage‑gated sodium channels on neuronal membranes, preventing the initiation and spread of nerve impulses. This reversible inhibition stops the transmission of pain signals from the treated area, resulting in localized anesthesia without affecting deeper tissues.

The exact amount to apply is determined by the prescribing clinician based on the size of the treatment area and the procedure. Typically, a thin layer is spread over the target site and covered with a suitable dressing for the time recommended by the healthcare professional.

Safety data for topical lidocaine/prilocaine use in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks and decide whether the product is appropriate for each individual patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with single‑agent products such as benzocaine or lidocaine alone, the lidocaine‑prilocaine combination often provides a broader onset and slightly longer duration of anesthesia. The dual‑action can improve patient comfort for procedures that require both rapid onset and sustained numbness, while maintaining a similar safety profile when used as directed.

Store Lidocaine Prilocaine Zentiva at room temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in its original packaging until use to maintain product stability.

The product is applied topically to intact skin or mucous membranes. After cleaning the area, a thin, even layer is spread over the target site and may be covered with an occlusive dressing if recommended. The duration of application is guided by the prescriber, typically ranging from a few minutes to up to an hour.

Serious adverse events, although rare, include systemic toxicity such as central nervous system symptoms (dizziness, seizures) and cardiac arrhythmias if large surface areas are treated. Methemoglobinemia, a blood disorder linked to prilocaine, can also occur, especially in susceptible individuals or when excessive amounts are absorbed.

Individuals with a known hypersensitivity to lidocaine, prilocaine, or any amide‑type local anesthetic should avoid this product. It is also contraindicated on broken or inflamed skin, and caution is advised for patients with severe cardiac, hepatic, or renal impairment until a clinician evaluates the risk.